ACADL: Unlocking The Enigma of Fatty Acid Breakdown (G33)

Target Name: ACADL

NCBI ID: G33

ACADL

ACADL: Unlocking The Enigma of Fatty Acid Breakdown

ACADL, or Acyl-Coenzyme A Dehydrogenase Long Chain, is a protein that is involved in a critical metabolic pathway in the body. It is a enzyme that is responsible for the breakdown of long chains of fatty acids, which are a vital source of energy for the body.

The breakdown of fatty acids into smaller chains of fatty acids, which are then used to create energy, is a process that is regulated by a complex network of enzymes. ACADL is one of these enzymes, and it is involved in the breakdown of long chains of fatty acids.

ACADL is a protein that is expressed in many different tissues throughout the body, including the brain, heart, and muscles. It is also expressed in the liver, where it is involved in the metabolism of fatty acids.

One of the key functions of ACADL is its role in the breakdown of long chains of fatty acids. This is an important process for the body, as the breakdown of fatty acids provides the energy that is needed for many different cellular functions.

In addition to its role in the breakdown of fatty acids, ACADL is also involved in the regulation of cellular processes. For example, it is has been shown to be involved in the regulation of the levels of certain chemicals in the brain, such as dopamine and neurotransmitters.

Another function of ACADL is its role in the detoxification of harmful substances. Many harmful substances, such as drugs and toxins, are metabolized by ACADL and then excreted from the body.

Despite its important role in many different cellular processes, ACADL is not yet a well-targeted drug or biomarker. This is because its function is not well understood, and it is difficult to identify potential drug targets or biomarkers for ACADL.

In conclusion, ACADL is a protein that is involved in the breakdown of long chains of fatty acids and the regulation of cellular processes. It is an important protein that plays a critical role in the body, and further research is needed to fully understand its function and potential as a drug target or biomarker.

Protein Name: Acyl-CoA Dehydrogenase Long Chain

Functions: Long-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats (By similarity). The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (By similarity). Among the different mitochondrial acyl-CoA dehydrogenases, long-chain specific acyl-CoA dehydrogenase can act on saturated and unsaturated acyl-CoAs with 6 to 24 carbons with a preference for 8 to 18 carbons long primary chains (PubMed:8823175, PubMed:21237683)

The "ACADL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACADL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets